Related Experiment Video
Updated: Jul 13, 2026

09:49
Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
Published on: December 28, 2021
Erectile dysfunction in spinal cord-injured men: different treatment options
M N Moemen1, I Fahmy, M AbdelAal
1Cairo University, Almanial, Cairo, Egypt.
International Journal of Impotence Research
|August 4, 2007
Summary
Sildenafil and intracorporal injection (ICI) effectively treat erectile dysfunction (ED) in men with spinal cord injury (SCI). Patients preferred sildenafil due to its ease of use, making it a widely accepted option.
Area of Science:
- Urology
- Rehabilitation Medicine
- Sexual Medicine
Background:
- Erectile dysfunction (ED) is a common complication in men with spinal cord injury (SCI).
- Various treatment modalities exist for ED in SCI patients, including pharmacotherapy, intracavernous injections, and mechanical devices.
- Patient preference and treatment efficacy are crucial factors in managing ED in this population.
Purpose of the Study:
- To compare the efficacy, safety, and patient preference of sildenafil, intracorporal injection (ICI), and vacuum constriction devices (VCD) for treating ED in men with SCI.
- To determine the most effective and preferred treatment option for ED in SCI patients.
Main Methods:
- A study included sixty men with SCI and ED, divided into three groups.
- Group A received sildenafil; Group B received ICI then switched to sildenafil; Group C used VCD then switched to sildenafil.
- Erection was evaluated using the International Index of Erectile Function-Erectile Function (IIEF-EF) before and after each treatment.
Main Results:
- Ninety percent of patients reported improved erections with sildenafil and ICI treatments.
- Seventy percent of patients reported improved erections with VCD.
- Fourteen patients preferred sildenafil due to its easier administration route.
Conclusions:
- Sildenafil is the most effective and widely accepted treatment for ED in men with SCI.
- ICI and VCD therapy should be considered based on individual patient preference and choice.
Related Concept Videos
Disorders of the Male Reproductive System
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Male Sexual Response: Erection & Ejaculation
Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...